Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for negative symptoms in inpatient schizophrenia
IRCT201202067290N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of atorvastatin in schizophrenia, sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoint: Reduction of negative symptoms. Started Nov 2011; status: completed.
02
Drugs
atorvastatin
03
Conditions
schizophrenia
Beyond the preview
Go deeper on IRCT201202067290N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201202067290N1.